We're committed to reducing the incidence of melanoma for all Australians, by creating a network of advanced 3D imaging technology systems that will improve early detection and diagnosis, particularly within regional areas.
The Australian Cancer Research Foundation (ACRF) Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID) brings together three leading Australian universities in skin research; The University of Sydney, The University of Queensland and Monash University in Victoria.
Our goal is to integrate and leverage world-class research expertise that is unique to Australia, to provide technologically disruptive and reliable solutions for the early diagnosis of melanoma.
Together, we're creating a 3D total body skin imaging network, which will form an interconnected centre of excellence in diagnostic imaging of early melanoma.
In partnership with eHealth NSW, our project will deliver teledermatology with Local Health Services, providing a connected and far-reaching early melanoma detection technology and program.
The total body 3D imaging technology at the core of ACRF ACEMID will allow for objective and secure collection of surface photography in a few milliseconds. The generated avatars enable documentation of all skin surfaces (except soles of feet, scalp and areas covered by clothing) to unprecedented levels of detail.
Sequential photography at regular intervals will allow for the detection of new or changing lesions. This detailed photography, coupled with Artificial Intelligence (being developed by the consortium) will allow the implementation of quick and cost-effective skin screening and a reduction of melanoma incidence.
The ACRF ACEMID project has received a wonderful response from the community to participate in our research, we have received over 5700 expressions of interest for NSW since our National Launch took place in September 2021. The ACEMID team would like to thank everyone for their willingness to contribute to this important work.
All five Vectra WB360 are installed in New South Wales. Our three regional sites in Port Macquarie, Orange and Wagga Wagga are working closely with our metropolitan sites in Melanoma Institute Australia (Poche), Wollstonecraft and Westmead Hospital. We have amended our enrolment target for the ACEMID study and all NSW sites are no longer accepting expressions of interest (EoIs).
As of September 2025, all 15 ACEMID sites across the states of NSW, Qld and Vic have recruited a combined 9026 participants into our study, that is achieving 90% of our new recruitment target and we continue to work with our research partners to build capacity for the project.
The goals of the ACRF ACEMID cohort study are to:
The research and clinical strength underpinning the proposed ACRF ACEMID initiative include three complementary NHMRC-funded Centres of Research Excellence (CRE):
View a diagram of the ACEMID research structure (png, 289KB)
Chief Investigators
Associate Investigators
The Poche Centre, 40 Rocklands Road
Wollstonecraft NSW 2065 (opposite the Mater Hospital)
Phone: (02) 9911 7200
Department of Dermatology
Level 2 G2- Outpatient Clinics
Hawkesbury Road
Westmead NSW 2145
Phone: (02) 8890 7149
19-31 Morton Street
Port Macquarie NSW 2444
Phone: (02) 6589 2100
272 Anson Street
Orange NSW 2800
Phone: (02) 6398 7733
Docker Street Medical Centre
Suite 15, Level 2, 2 Docker Street
Wagga Wagga NSW 2650
Phone: (02)8526 3361
Mailing address
Westmead Hospital
Level 6, Block K Hawkesbury Road
The University of Sydney Faculty of Medicine and Health Westmead Clinical School
Westmead NSW, 2145
